We are pleased to announce a stimulating opportunity for aspiring researchers (from Italy and abroad) in the field of molecular oncology. We offer a predoctoral training program designed to prepare candidates for admission to the PhD course in Molecular Medicine at the University of Torino. Successful candidate(s) will be supported by a salary throughout the beginning of the PhD Course (November 1st, 2023).

A short term post-doctoral position is immediately available in the laboratory of prof. Licio Collavin at the University of Trieste (http://tinyurl.com/collavinlab) The lab is focused on the molecular mechanisms that determine cancer aggressiveness, with a special interest in function and regulation of the tumor suppressor DAB2IP, a Ras-GAP and signaling adaptor that modulates multiple oncogenic pathways. For more information, or to apply, feel free to write directly to prof. Collavin

The goal of our lab at the San Raffaele – Telethon institute for Gene Therapy (SR-TIGET) in Milan is to study the regulation of blood cell emergence during human embryonic development. To this aim, we use our innovative hESCs/hiPSCs platform and combine developmental cell and molecular biology to understand normal and pathological human hematopoietic development, with a particular interest in studying the genetic origins for blood disorders and developing novel strategies for their treatment.

A two-year post-doc position on the project entitled “The lncRNA PHOX2B-AS1 in the pathogenesis and as potential drug target in Congenital Central Hypoventilation Syndrome (CCHS)” founded by the Telethon Foundation, is available at the “Molecular Pharmacology” laboratory (PI Prof. Fornasari), Dept. of Medical Biotechnology and Translational Medicine, University of Milan.

We are looking for a highly motivated and enthusiastic individual to study the process of inflammation. In particular, the selected candidate will investigate the role of intracellular immune receptors in shaping immune responses under physiological and pathological conditions, such as chronic inflammatory diseases. These studies will collectively advance our understanding of inflammatory disorders and improve patients’ care.